Edwards Lifesciences Financial Diagnostics

EW -- USA Stock  

USD 153.46  0.84  0.55%

Edwards Lifesciences Corporation diagnostics interface makes it easy to digest most current publicly released information about Edwards Lifesciences as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Edwards Lifesciences price relationship with some important fundamental indicators such as market cap and management efficiency.

Edwards Lifesciences Note

The company has Price/Earnings To Growth (PEG) ratio of 2.28. Edwards Lifesciences Corporation had not issued any dividends in recent years. This company had 2:1 split on 2015-12-14. Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients in the United States and internationally. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in USA and traded on New York Stock Exchange. It employs 12200 people. To learn more about EDWARDS LIFESCIEN call Michael Mussallem at 949-250-2500 or check out http://www.edwards.com.

Edwards Lifesciences Alerts

Edwards Lifesciences Upcoming Events

Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 25, 2017

Edwards Lifesciences Earning Estimates

EPSEstimate Date
Quarterly Estimate0.83April 25, 2017
Edwards Lifesciences Corporation normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Edwards Lifesciences Thematic Classifications

Obamacare Repeal IdeaObamacare Repeal
Large healthcare related equities associated with Obamacare
Medical Equipment IdeaMedical Equipment
USA Equities from Medical Equipment industry as classified by Fama & French
Health Management IdeaHealth Management
Healthcare providers, hospitals
Healthcare IdeaHealthcare
USA Equities from Healthcare industry as classified by Fama & French

Institutional Investors

Security TypeSharesValue
Hardman Johnston Global Advisors LlcCommon Shares346.7 K50.5 M
Huntington National BankCommon Shares213.7 K31.1 M
Chicago Capital LlcCommon Shares186.8 K27.2 M
Bank Of MontrealCommon Shares176.1 K25.6 M
Scout Investments IncCommon Shares143.3 K20.9 M
Calamos Advisors LlcCommon Shares110.4 K16.1 M
Nisa Investment Advisors LlcCommon Shares102.4 K14.9 M

Market Capitalization

The company currently falls under 'Large-Cap' category with market capitalization of 32.17 B.

Profitablity

The company has Net Profit Margin (PM) of 16.25 % which may suggest that it has a good control over its expenditures, executes well on its competitive polices, or have a solid pricing strategies. This is very large. Likewise, it shows Net Operating Margin (NOM) of 30.64 % which signify that for every $100 of sales it has a net operating income of 0.31.

Management Efficiency

Edwards Lifesciences Corporation has Return on Asset (ROA) of 11.51 % which means that for every $100 of asset it generated profit of $11.51. This is typical in the industry. Likewise, it shows return on total equity (ROE) of 18.7 % which means that it produced $18.7 on every 100 dollars invested by current stockholders.

Stock Holders for Edwards Lifesciences

Information
Ratio
Value
At Risk
FranklinFranklin Small Mid Cap Growth R(0.08) (1.54) 
FranklinFranklin Small Mid Cap Growth R6(0.11) (1.54) 
AMGAMG Managers Montag Caldwell Balancd N(0.26) (0.49) 
VanguardVanguard Mid Cap Index Investor(0.16) (0.75) 
VanguardVanguard Mid Cap Index Admiral(0.11) (1.40) 
DreyfusDreyfus US Equity I 0.05 (1.01) 
GoldmanGoldman Sachs Growth Opportunities R6(0.12) (1.34) 
GoldmanGoldman Sachs Growth Opportunities Svc(0.10) (1.11) 
PrincipalPrincipal MidCap Growth III R4(0.13) (1.09) 
MFSMFS Blended Research Mid Cap Eq A(0.05) (0.73) 
BairdBaird MidCap Inv(0.06) (1.28) 
CatalystCatalyst Insider Buying I 0.1  0.00 
SSQSSQ Hillsdale U S Equity GIF Premium 0.00  0.00 
BrownBrown Advisory Global Leaders Investor(0.0481) (1.30) 
Ivy MidIvy Mid Cap Growth N(0.0363) (2.04) 
BMO EqBMO Eq Wght US HlthCare Hdgd to CAD ETF(0.0001) (1.09) 
SPDR SPSPDR SP Health Care Equipment ETF(0.09) (1.88) 
Ivy MidIvy Mid Cap Growth Y(0.09) (0.87) 
Ivy MidIvy Mid Cap Growth R(0.05) (0.60) 
Ivy MidIvy Mid Cap Growth C(0.1) (0.89) 

Technical Drivers

Edwards Lifesciences Corporation shows Coefficient Of Variation of 4,302 and Mean Deviation of 0.9632. Edwards Lifesciences technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm future prices. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for Edwards Lifesciences Corporation which can be compared to its rivals. Please confirm Edwards Lifesciences Information Ratio, Potential Upside as well as the relationship between Potential Upside and Kurtosis to decide if Edwards Lifesciences is priced favorably providing market reflects its regular price of 153.46 per share. Given that Edwards Lifesciences has Jensen Alpha of 0.0849, we urge you verify Edwards Lifesciences Corporation prevailing market performance to make sure the company can sustain itself at future point.

Edwards Lifesciences Price Movement Analysis

Study
Time Period
Deviations up
Deviations down
MA Type
  Portfolio Suggestion    
  
Execute Study
 
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Edwards Lifesciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Edwards Lifesciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

Edwards Lifesciences Insider Trading Activities

Edwards Lifesciences Outstanding Bonds

Edwards Lifesciences Predictive Indicators

Edwards Lifesciences Forecast Models

Recommendations

Edwards Lifesciences Analyst Recommendations
Target PriceAdvice# of Analysts
118.41Buy17Odds
Edwards Lifesciences Corporation current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Edwards Lifesciences Analyst Advice  
Additionally see Investing Opportunities. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">